|
KR20200104265A
|
|
An oral sustained-release tablet comprising tianeptine or pharmaceutically acceptable salts thereof
|
|
KR20190075872A
|
|
An animal feed form with poultry productivity improvement
|
|
KR20200138556A
|
|
A syrup composition comprising montelukast or pharmaceutically acceptable salt thereof
|
|
KR20180120634A
|
|
Delayed release enzyme preparations and the preparation method for the same
|
|
KR20180101307A
|
|
An oral sustained-release tablet comprising tianeptine or pharmaceutically acceptable salts thereof
|
|
KR20170088783A
|
|
Wetgranulation composition containing mirabegron
|
|
KR20170058888A
|
|
Artemisia extract
|
|
KR20180089811A
|
|
A high swellable sustained-release triple-layer tablet containing pregabalin
|
|
KR20180089807A
|
|
An orally administered sustained-release triple-layer tablet containing pregabalin
|
|
KR20160076511A
|
|
Artemisia extract
|
|
KR20150141383A
|
|
Controlled-release pellet compositions containing pseudoephedrine
|
|
KR20110130373A
|
|
Delayed release enzyme preparations and the preparation method for the same
|
|
KR20110102260A
|
|
An animal feed form with poultry productivity improvement
|
|
KR20120137998A
|
|
A dosage form with increased stability comprising tamsulosin and finasteride
|
|
KR20120093500A
|
|
An oral sustained-release triple layer tablet comprising tamsulosin or pharmaceutically acceptable salts thereof
|
|
KR20120092993A
|
|
An oral sustained-release tablet comprising tianeptine or pharmaceutically acceptable salts thereof
|
|
KR20090010248A
|
|
Artemisia extract
|
|
KR100900725B1
|
|
A preparation method of artemisia extract containing high content of eupatilin
|
|
KR20090096070A
|
|
New method of manufacturing oral solid dosage form containing valsartan
|
|
KR20090057841A
|
|
A sustained-release multiple unit dosage form containing galantamine hydrobromide
|
